Send feedback

CPS1 p.Pro346Ser

c.1036C>T · rs1559093517 · VCV2171457

Benign Single submitter
Classification
Benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.2364 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 8.48e-05%, nfe)
Missense predictors
2/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
carbamoyl phosphate synthetase I deficiency disease

Computational evidence

Protein change
AlphaMissense0.2364likely benign
REVEL0.759pathogenic-leaning
SaProtLLR -11.84damaging
⇒ REVEL and SaProt call this damaging; AlphaMissense does not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.7GERP 2.7, phastCons 1
Regional constrainto/e 0.93unconstrained · MANE · 121 kb · p 0.0019 · regional, not allelic
Overall
CADD25.5PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.48e-05% European (non-Finnish) · 1/1,178,996 alleles
Overall 0.000137% 2/1,460,234 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,368
European (non-Finnish)grpmax 8.48e-05% 1,178,996

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CPS1
Protein
p.Pro346Ser
Coding
c.1036C>T
MANE Select
NM_001875
dbSNP
rs1559093517
Type
single nucleotide variant
Location
chr2:210591919 (GRCh38)
Gene constraint
LOEUF 0.764 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 93.80 · 14 PDB
Residue 346
the glutamine amidotransferase type-1 domain
Full CPS1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

carbamoyl phosphate synthetase I deficiency disease — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Carbamoyl-phosphate synthetase 1 deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
All ages

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cps1-p-pro346ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown